• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p21和p53蛋白表达及增殖细胞核抗原在胰腺癌中的临床意义

Clinical significance of expression of p21 and p53 proteins and proliferating cell nuclear antigen in pancreatic cancer.

作者信息

Dang Cheng-Xue, Han Yue, Qin Zhao-Yin, Wang Ya-Jun

机构信息

Department of Tumor Surgery, First Hospital, Xi'an Jiaotong University, Xi'an 710061, China.

出版信息

Hepatobiliary Pancreat Dis Int. 2002 May;1(2):302-5.

PMID:14612290
Abstract

OBJECTIVE

To study the clinical significance and effect of p21, p53 protein as well as proliferating cell nuclear antigen (PCNA) on the occurrence and development of pancreatic carcinoma.

METHOD

p21, p53 protein and PCNA expressions were detected in specimens from 30 patients with pancreatic carcinoma and 3 samples of normal pancreatic tissue by immunohistochemistry. The data were analyzed together with clinical findings.

RESULTS

The positive expression rates of p21 and p53 proteins were 75.0% and 57.3% respectively in pancreatic carcinoma, which were significantly different from those in the normal tissue (P<0.05). p21 and p53 proteins were positively correlated (P<0.05). The positive expression of PCNA was 43.33%+/-17.99%, that was significantly higher than that in the normal pancreatic tissue (P<0.05). The expression of PCNA was correlated with the histological grade (P<0.05). The positive expression rate was consistent with the exacerbation of cancer. The expression was also correlated significantly with prognosis and p53 expression (P<0.05).

CONCLUSIONS

The occurrence and development of pancreatic cancer are the result of associated function for many oncogenes and antioncogenes. PCNA may be helpful to identify malignant degree and prognosis of pancreatic cancer.

摘要

目的

研究p21、p53蛋白以及增殖细胞核抗原(PCNA)在胰腺癌发生发展中的临床意义及作用。

方法

采用免疫组织化学法检测30例胰腺癌患者标本及3例正常胰腺组织标本中p21、p53蛋白和PCNA的表达情况,并结合临床资料进行分析。

结果

胰腺癌中p21和p53蛋白的阳性表达率分别为75.0%和57.3%,与正常组织相比差异有统计学意义(P<0.05)。p21和p53蛋白呈正相关(P<0.05)。PCNA的阳性表达率为43.33%±17.99%,显著高于正常胰腺组织(P<0.05)。PCNA的表达与组织学分级相关(P<0.05),阳性表达率随癌症进展而升高。其表达还与预后及p53表达显著相关(P<0.05)。

结论

胰腺癌的发生发展是多种癌基因和抑癌基因共同作用的结果。PCNA可能有助于判断胰腺癌恶性程度及预后。

相似文献

1
Clinical significance of expression of p21 and p53 proteins and proliferating cell nuclear antigen in pancreatic cancer.p21和p53蛋白表达及增殖细胞核抗原在胰腺癌中的临床意义
Hepatobiliary Pancreat Dis Int. 2002 May;1(2):302-5.
2
[Expression of p21(WAF1) and its relationship with p53 and PCNA protein in epithelial ovarian cancer].[上皮性卵巢癌中p21(WAF1)的表达及其与p53和PCNA蛋白的关系]
Ai Zheng. 2004 Jan;23(1):74-80.
3
[Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].[COX-2、p53、增殖细胞核抗原及nm23在胃癌中的表达意义及其行为]
Ai Zheng. 2002 Jun;21(6):619-24.
4
Tumour suppressor protein (p53), apoptosis inhibiting protein (Bcl-2) and proliferating cell nuclear antigen (PCNA) expressions in a rat pancreatic tumour model.大鼠胰腺肿瘤模型中肿瘤抑制蛋白(p53)、凋亡抑制蛋白(Bcl-2)和增殖细胞核抗原(PCNA)的表达
Anticancer Res. 2007 Jan-Feb;27(1A):23-6.
5
Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN).导管腺癌和胰腺上皮内瘤变(PanIN)中细胞周期和增殖标志物的差异表达。
Pathology. 2010 Apr;42(3):229-34. doi: 10.3109/00313021003631379.
6
[Expressions of p53 and Gadd45a proteins in human pancreatic cancer and their clinicopathological significance].p53和Gadd45a蛋白在人胰腺癌中的表达及其临床病理意义
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Oct;27(5):628-32.
7
Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.细胞周期蛋白D1、E及细胞周期蛋白依赖性激酶抑制剂p21waf1/cip1、p27kip1在结直肠癌中的表达模式:与其他细胞周期调节因子(pRb、p53、Ki-67及PCNA)及临床病理特征的相关性
Int J Clin Pract. 2008 Nov;62(11):1736-43. doi: 10.1111/j.1742-1241.2006.01105.x.
8
[Relationship between expression of p57(kip2), cyclin E protein, PCNA, and clinicopathological factors in human pancreatic cancer].[人胰腺癌中p57(kip2)、细胞周期蛋白E蛋白、增殖细胞核抗原的表达与临床病理因素的关系]
Ai Zheng. 2003 Jul;22(7):705-9.
9
Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.萎缩性口腔扁平苔藓及咀嚼槟榔患者中p53和增殖细胞核抗原(PCNA)的高表达。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Apr;99(4):471-8. doi: 10.1016/j.tripleo.2004.10.018.
10
[Relationship between expression of tumor suppressor protein p21 and p53 and cell proliferation in the gastric carcinoma].
Hunan Yi Ke Da Xue Xue Bao. 1998;23(5):441-3.

引用本文的文献

1
Expression of chosen cell cycle and proliferation markers in pancreatic intraepithelial neoplasia.胰腺上皮内瘤变中所选细胞周期和增殖标志物的表达
Prz Gastroenterol. 2018;13(2):118-126. doi: 10.5114/pg.2018.75824. Epub 2018 May 16.
2
Phenethyl isothiocyanate inhibits proliferation and induces apoptosis in pancreatic cancer cells in vitro and in a MIAPaca2 xenograft animal model.异硫氰酸苯乙酯在体外和MIAPaca2异种移植动物模型中均可抑制胰腺癌细胞的增殖并诱导其凋亡。
Nutr Cancer. 2014;66(4):747-55. doi: 10.1080/01635581.2013.795979. Epub 2013 Nov 6.
3
The influence of the total flavonoids of Hedysarum polybotry on the proliferation, cell cycle, and expressions of p21Ras and proliferating cell nuclear antigen gene in erythroleukemia cell line K562.
黄花棘豆总黄酮对红白血病细胞系 K562 增殖、细胞周期及 p21Ras、增殖细胞核抗原基因表达的影响。
Chin J Integr Med. 2012 May;18(5):385-90. doi: 10.1007/s11655-011-0952-3. Epub 2012 Jan 12.
4
Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.Meta 分析胰腺切除术后肿瘤组织中免疫组化预后标志物的作用
Br J Cancer. 2011 Apr 26;104(9):1440-51. doi: 10.1038/bjc.2011.110. Epub 2011 Mar 29.
5
The molecular targets for the diagnosis and treatment of pancreatic cancer.胰腺癌的诊断和治疗的分子靶点。
Gut Liver. 2010 Dec;4(4):433-49. doi: 10.5009/gnl.2010.4.4.433. Epub 2010 Dec 17.